204 related articles for article (PubMed ID: 17435860)
1. [Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia].
Vilar L; Moura E; Canadas V; Gusmão A; Campos R; Leal E; Teixeira L; Santos V; Gomes B; Lima M; Paiva R; Albuquerque JL; Egito CS; Botelho CA; Azevedo M; Casulari LA; Naves LA
Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):86-91. PubMed ID: 17435860
[TBL] [Abstract][Full Text] [Related]
2. Importance of macroprolactinemia in hyperprolactinemia.
Kasum M; Pavičić-Baldani D; Stanić P; Orešković S; Sarić JM; Blajić J; Juras J
Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():28-32. PubMed ID: 25461348
[TBL] [Abstract][Full Text] [Related]
3. [Macroprolactinemia in the differential diagnosis of hyperprolactinemia].
Toldy E; Löcsei Z; Szabolcs I; Kneffel P; Góth M; Szöke D; Kovács LG
Orv Hetil; 2003 Oct; 144(43):2121-7. PubMed ID: 14661444
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and reproductive manifestations of macroprolactinemia.
Kalsi AK; Halder A; Jain M; Chaturvedi PK; Sharma JB
Endocrine; 2019 Feb; 63(2):332-340. PubMed ID: 30269265
[TBL] [Abstract][Full Text] [Related]
5. Macroprolactinemia in patients with hyperprolactinemia: an experience from a single tertiary center.
Chutpiboonwat P; Yenpinyosuk K; Sridama V; Kunjan S; Klaimukh K; Snabboon T
Pan Afr Med J; 2020; 36():8. PubMed ID: 32550971
[TBL] [Abstract][Full Text] [Related]
6. Frequency of Macroprolactin in Hyperprolactinemia.
Sherazi NA; Baig MZ; Khan AH
J Coll Physicians Surg Pak; 2018 Feb; 28(2):93-97. PubMed ID: 29394965
[TBL] [Abstract][Full Text] [Related]
7. Macroprolactinemia: the consequences of a laboratory pitfall.
Toldy E; Löcsei Z; Szabolcs I; Góth MI; Kneffel P; Szöke D; Kovács GL
Endocrine; 2003 Dec; 22(3):267-73. PubMed ID: 14709800
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Macroprolactinemia in People Detected to Have Hyperprolactinemia.
Sharma LK; Dutta D; Sharma N; Kulshreshtha B; Lal S; Sethi R
J Lab Physicians; 2021 Dec; 13(4):353-357. PubMed ID: 34975255
[No Abstract] [Full Text] [Related]
9. Macroprolactinemia: diagnostic, clinical, and pathogenic significance.
Shimatsu A; Hattori N
Clin Dev Immunol; 2012; 2012():167132. PubMed ID: 23304187
[TBL] [Abstract][Full Text] [Related]
10. Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia.
Kasum M; Orešković S; Čehić E; Šunj M; Lila A; Ejubović E
Taiwan J Obstet Gynecol; 2017 Dec; 56(6):719-724. PubMed ID: 29241908
[TBL] [Abstract][Full Text] [Related]
11. Detection of macroprolactinemia with the polyethylene glycol precipitation test in systemic lupus erythematosus patients with hyperprolactinemia.
Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
Lupus; 2001; 10(5):340-5. PubMed ID: 11403264
[TBL] [Abstract][Full Text] [Related]
12. [Screening and detection of patients with macroprolactinemia by application of polyethylene glycol precipitation method].
Chen YJ; Zhou YL; Xu L; Yan J
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2014 Mar; 43(2):187-92. PubMed ID: 24782376
[TBL] [Abstract][Full Text] [Related]
13. Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up.
Radavelli-Bagatini S; Lhullier FL; Mallmann ES; Spritzer PM
Neuro Endocrinol Lett; 2013; 34(3):207-11. PubMed ID: 23685418
[TBL] [Abstract][Full Text] [Related]
14. Macroprolactinemia in hyperprolactinemic infertile women.
Thirunavakkarasu K; Dutta P; Sridhar S; Dhaliwal L; Prashad GR; Gainder S; Sachdeva N; Bhansali A
Endocrine; 2013 Dec; 44(3):750-5. PubMed ID: 23543432
[TBL] [Abstract][Full Text] [Related]
15. Macroprolactinemia: new insights in hyperprolactinemia.
Kasum M; Oreskovic S; Zec I; Jezek D; Tomic V; Gall V; Adzic G
Biochem Med (Zagreb); 2012; 22(2):171-9. PubMed ID: 22838183
[TBL] [Abstract][Full Text] [Related]
16. Clinical and laboratory features greatly overlap in patients with macroprolactinemia or monomeric hyperprolactinemia.
Vilar L; Naves LA; Freitas MC; Lima M; Canadas V; Albuquerque JL; Lyra R; Azevedo MF; Casulari LA
Minerva Endocrinol; 2007 Jun; 32(2):79-86. PubMed ID: 17557033
[TBL] [Abstract][Full Text] [Related]
17. Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia.
Suliman AM; Smith TP; Gibney J; McKenna TJ
Clin Chem; 2003 Sep; 49(9):1504-9. PubMed ID: 12928232
[TBL] [Abstract][Full Text] [Related]
18. Establishment of reference intervals of monomeric prolactin to identify macroprolactinemia in Chinese patients with increased total prolactin.
Hu Y; Ni J; Zhang B; Cheng W; Zhang H; Ye H; Ji L; Lu B; Guan M
BMC Endocr Disord; 2021 Oct; 21(1):197. PubMed ID: 34620143
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of Polyethylene-Glycol Precipitation As a Screening Method for Macroprolactinemia].
Yamakami A; Takahashi R; Fukazawa C; Tanaka C; Takeda K
Rinsho Byori; 2016 Sep; 64(9):1012-1015. PubMed ID: 30609453
[TBL] [Abstract][Full Text] [Related]
20. Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia.
Overgaard M; Pedersen SM
Clin Chem Lab Med; 2017 Oct; 55(11):1744-1753. PubMed ID: 28236625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]